Business

AstraZeneca CEO Discusses AI's Impact on Drug Development

Updated 2026-06-06 11:15 UTC 2 sources Neutral

AstraZeneca CEO Pascal Soriot highlighted how artificial intelligence is transforming drug development, enhancing the company’s research and decision-making processes.

Coverage timeline — 2 articles

CNBC

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.

2026-06-05 22:26 UTC

MarketWatch

The key to the upcoming Fed meeting? How Warsh reacts to all the hints of a rate hike.

The new Fed chair might make swift changes to how the central bank communicates.

2026-06-06 11:00 UTC